IOVA - Iovance Biotherapeutics Inc
Iovance Biotherapeutics Inc Logo

IOVA - Iovance Biotherapeutics Inc

https://www.iovance.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
Neutral
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday - Amber International ( NASDAQ:AMBR ) , Ascentage Pharma Group ( NASDAQ:AAPG )
Benzinga • 2 weeks, 6 days ago • score: 0.02
U.S. stocks were mixed, with the Dow Jones index falling more than 200 points on Monday. Shares of Keurig Dr Pepper Inc. KDP fell sharply during Monday's session after the company announced the acquisition of JDE Peet's. Keurig Dr Pepper shares dipped 7.8% to $32.38 on Monday.
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company is headquartered in San Carlos, California.

52W High
$12.51
52W Low
$1.64
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.82
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-8.68
EV/Revenue (<3 favorable)
2.70
P/S (TTM) (<3 favorable)
3.73
P/B (<3 favorable)
1.29
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
0.36%
Institutions (25–75% balanced)
69.36%
Shares Outstanding
361,854,000
Float
303,632,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
241,525,000
Gross Profit (TTM)
49,754,000
EPS (TTM)
-1.21
Profit Margin (>10% good)
-1.61%
Operating Margin (TTM) (higher better)
-1.90%
ROE (TTM) (>15% strong)
-0.53%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.93
Momentum
Bearish momentum
Value
-0.0613
Previous
-0.0863
Trend
Rising
Signal Cross
No cross
As of
Sep. 05, 2025